Patent · US Active

Binding molecule specific for CD73 and use of binding molecule

US11174319B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

JACOBIO PHARMACEUTICALS CO., LTD. · CN

Inventors

Qinghao LIU · Beijing, CN
Wenlai Zhou · Cambridge, US
Haiyan Yang · 安丰镇, CN
Hongling WANG · Shanghai, CN

Key dates

Filing date	Apr 26, 2021
Grant date	Nov 16, 2021
Priority date	—
Expiry date	Apr 26, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A binding molecule specific for CD73 and a use of the binding molecule. Specifically, provided are a separate antibody binding CD73 and inhibiting the activity of CD73 or an antigen binding part of the separate antibody, and a use of the separate antibody or the antigen binding part thereof in treatment of diseases; also provided are a nucleic acid molecule encoding the separate antibody or the antigen binding part thereof, an expression vector for expressing the separate antibody or the antigen binding part thereof, a host cell, and a preparation method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.